Previous studies have confirmed that KRAS-driven cancer cells altered the content and structure of the tumor microenvironment, hence altering nutrient metabolism and oxygen availability in solid tumors, modifying the tumor microenvironment and limiting the proliferation and activity of T cells (56–58). This evidence concerns the gene KRAS and cancer.